lunes, 26 de agosto de 2019

Path BioAnalytics Licenses Cavosonstat From Laurel Therapeutics

Path BioAnalytics Licenses Cavosonstat From Laurel Therapeutics

Cystic Fibrosis News Today

Path BioAnalytics Acquires Cavosonstat From Laurel Therapeutics for Further Study

No hay comentarios:

Publicar un comentario